6461 - 6470 of 9118 Results
Title
Year
-
OPENTitle: New transgenic models of Parkinson's disease using genome editing technologyJournal Name: Neurología (English Edition)Publisher: Elsevier BVVol: 35Issue #: 7Start Page: 486End Page: 499Publication Date:Open Access(OA) Status: OPENLicense: cc-by-nc-ndDOI - Digital Object Identifier: 10.1016/j.nrleng.2017.08.006Best OA location URL: https://doi.org/10.1016/j.nrleng.2017.08.006Citation Count: 3
-
OPENTitle: Early postnatal injections of whole vaccines compared to placebo controls: Differential behavioural outcomes in miceJournal Name: Journal of Inorganic BiochemistryPublisher: Elsevier BVVol: 212Issue #:Start Page: 111200End Page: 111200Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1016/j.jinorgbio.2020.111200Best OA location URL: https://www.sciencedirect.com/science/article/am/pii/S0162013420302282?via%3DihubCitation Count: 5
-
OPENTitle: The Library Derived 4554W Peptide Inhibits Primary Nucleation of α-SynucleinJournal Name: Journal of Molecular BiologyPublisher: Elsevier BVVol: 432Issue #: 24Start Page: 166706End Page: 166706Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1016/j.jmb.2020.11.005Best OA location URL: https://researchportal.bath.ac.uk/en/publications/fb730497-1b80-42eb-b3a3-b52e364bb049Citation Count: 16
- Mild cognitive impairment and dementia in motor manifest Huntington's disease: Classification and prevalence2019RESTRICTEDTitle: Mild cognitive impairment and dementia in motor manifest Huntington's disease: Classification and prevalenceJournal Name: Journal of the Neurological SciencesPublisher: Elsevier BVVol: 408Issue #:Start Page: 116523End Page: 116523Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1016/j.jns.2019.116523Citation Count: 53
- A validation of a self-administered screening test for Parkinson's disease2020RESTRICTEDTitle: A validation of a self-administered screening test for Parkinson's diseaseJournal Name: Journal of the Neurological SciencesPublisher: Elsevier BVVol: 418Issue #:Start Page: 117116End Page: 117116Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1016/j.jns.2020.117116Citation Count: 5
-
OPENTitle: A revolution in biochemistry and molecular biology education informed by basic research to meet the demands of 21st century career pathsJournal Name: Journal of Biological ChemistryPublisher: Elsevier BVVol: 295Issue #: 31Start Page: 10653End Page: 10661Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.1074/jbc.aw120.011104Best OA location URL: https://doi.org/10.1074/jbc.aw120.011104Citation Count: 27
- Low cerebrospinal fluid volume and the risk for post-lumbar puncture headaches2020RESTRICTEDTitle: Low cerebrospinal fluid volume and the risk for post-lumbar puncture headachesJournal Name: Journal of the Neurological SciencesPublisher: Elsevier BVVol: 417Issue #:Start Page: 117059End Page: 117059Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1016/j.jns.2020.117059Citation Count: 8
-
OPENTitle: The age-related trajectory of visual attention neural function is altered in adults living with HIV: A cross-sectional MEG studyJournal Name: EBioMedicinePublisher: Elsevier BVVol: 61Issue #:Start Page: 103065End Page: 103065Publication Date:Open Access(OA) Status: OPENLicense: cc-by-nc-ndDOI - Digital Object Identifier: 10.1016/j.ebiom.2020.103065Best OA location URL: http://www.thelancet.com/article/S2352396420304412/pdfCitation Count: 31
- Diphenyl triazine hybrids inhibit α-synuclein fibrillogenesis: Design, synthesis and in vitro efficacy studies2020RESTRICTEDTitle: Diphenyl triazine hybrids inhibit α-synuclein fibrillogenesis: Design, synthesis and in vitro efficacy studiesJournal Name: European Journal of Medicinal ChemistryPublisher: Elsevier BVVol: 207Issue #:Start Page: 112705End Page: 112705Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1016/j.ejmech.2020.112705Citation Count: 16
- Angiotensin II type 1 receptor blocker telmisartan inhibits the development of transient hypoxia and improves tumour response to radiation2020RESTRICTEDTitle: Angiotensin II type 1 receptor blocker telmisartan inhibits the development of transient hypoxia and improves tumour response to radiationJournal Name: Cancer LettersPublisher: Elsevier BVVol: 493Issue #:Start Page: 31End Page: 40Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1016/j.canlet.2020.07.015Citation Count: 24